Should I buy Sonic Healthcare stock in 2025?
Is Sonic Healthcare stock a buy right now?
Sonic Healthcare Limited (ASX: SHL) currently trades at approximately $26.06 per share, with an average daily trading volume of 1.16 million shares—a measure of its strong investor following. The stock has shown resilience, stabilising after a minor one-year decline and now trading near its 50-day and 200-day moving averages. Notably, the recent acquisition of the LADR/Kramer Group is poised to contribute more than $80 million annually to EBITDA from July 2025, underscoring Sonic Healthcare's capacity for strategic, earnings-accretive expansion. The company's continued push into European markets and digital health, alongside a robust full-year profit outlook, is fostering growing market optimism. Healthcare diagnostics remain a defensive, in-demand sector, particularly amid demographic trends favouring growth in preventative and routine care. This backdrop—along with a very attractive 4.11% dividend yield and recent director share purchases—suggests investors are recognising Sonic Healthcare’s long-term stability and upside potential. The consensus from more than 34 national and international banks sets a target price at $33.88, reflecting confidence in both Sonic’s core operations and its recent growth initiatives.
- Global market leader in medical diagnostics with stable revenue streams.
- Attractive 4.11% dividend yield, providing steady income.
- Successful track record in strategic acquisitions and integrations.
- Low beta (0.43), indicating lower volatility relative to the market.
- Ongoing digital transformation and automation initiatives.
- Integration risk exists with recent LADR/Kramer acquisition, though outlook remains constructive.
- Healthcare regulation changes could modestly impact funding but are generally manageable.
- What is Sonic Healthcare?
- How much is Sonic Healthcare stock?
- Our full analysis on Sonic Healthcare </b>stock
- How to buy Sonic Healthcare stock in Australia?
- Our 7 tips for buying Sonic Healthcare stock
- The latest news about Sonic Healthcare
- FAQ
Why trust HelloSafe?
At HelloSafe, our expert has been monitoring Sonic Healthcare's performance for more than three years. Each month, hundreds of thousands of Australians turn to us to make sense of market trends and uncover attractive investment opportunities. Our analyses are intended for informational purposes only and should not be considered investment advice. Consistent with our ethical charter, we have never received, and will never accept, any form of payment from Sonic Healthcare.
What is Sonic Healthcare?
| Indicator | Value | Analysis |
|---|---|---|
| 🏳️ Nationality | Australian | Headquartered in Australia, Sonic is a global leader in medical diagnostics. |
| 💼 Market | ASX (Australian Securities Exchange) | Listed on the ASX, providing liquidity and access for Australian retail investors. |
| 🏛️ ISIN code | AU000000SHL7 | Unique identifier for Sonic Healthcare shares on global financial markets. |
| 👤 CEO | Dr. Colin Goldschmidt | Long-serving CEO provides stability and deep industry expertise. |
| 🏢 Market cap | A$12.52 billion | Mid-large cap status offers scale and resilience in the healthcare sector. |
| 📈 Revenue | A$4.7 billion (HY 2024); Projected FY: ~A$9.4bn | Strong revenue base demonstrates global reach and growing service demand. |
| 💹 EBITDA | A$827 million (HY 2024); FY2025: A$1.70–1.75bn | Profitability is increasing, supported by organic growth and recent acquisitions. |
| 📊 P/E Ratio | 22.9 (trailing); 20.8 (forward) | Reasonable valuation for a defensive, growing healthcare company; may offer re-rating potential. |
How much is Sonic Healthcare stock?
The price of Sonic Healthcare stock is rising this week. As of today, shares are trading at $26.06 AUD, marking a 1.2% gain (+$0.32) over the past 24 hours and showing a relatively stable trend through the week.
The company holds a market capitalization of $12.52 billion, with an average three-month daily trading volume of 1.16 million shares. Sonic Healthcare currently reports a trailing P/E ratio of 22.9, a dividend yield of 4.11%, and a stock beta of 0.43, indicating lower-than-average volatility.
With its strong track record and defensive sector positioning, Sonic Healthcare offers investors a compelling blend of stability and income potential.
Check out the best brokers in Australia!Compare brokersOur full analysis on Sonic Healthcare stock
After an in-depth review of Sonic Healthcare’s recent financials and share price trajectory, our proprietary algorithms combine financial, technical, and sectoral analysis to provide a timely outlook. The findings reaffirm Sonic’s position as a premier global diagnostics leader, showcasing resilience amidst transition, strategic reinvestment, and international strength. Why might Sonic Healthcare once again emerge as a strategic entry point in healthcare and diagnostics for 2025?
Recent Performance and Market Context
Sonic Healthcare (ASX: SHL) has shown relative share price stability over the past year, trading at $26.06—unchanged year-on-year and slightly down six months (-0.84%). This steadiness amid sector volatility suggests underlying investor conviction.
- Remarkable H1 FY2025 Results: Net profit surged to A$236.7 million (+17% YoY), and EBITDA climbed to A$827 million (+12.3% YoY), reflecting robust demand and operational efficiency.
- Dividend Consistency: A healthy 4.11% yield highlights sustained profitability and sets SHL apart among ASX healthcare majors, appealing to both growth and income investors.
- Market Cap of $12.5 Billion: This underscores Sonic’s dominance and reputation both within Australia and on the global stage.
At the sector level, macro trends are favorable:
- Aging global demographics and post-pandemic recalibration are fueling diagnostics demand.
- Growing healthcare expenditure across Sonic’s markets creates fertile ground for competition, as governments and insurers increasingly prioritize preventive diagnostics.
Technical Analysis
Sonic Healthcare’s technical profile currently signals an interesting setup for opportunistic entry.
- Moving Averages: The price sits just below the 50-day ($26.09) and 200-day ($27.22) averages. While this typically signals consolidation, the proximity to these support levels indicates potential for a bullish reversal on positive news or earnings momentum.
- Key Levels:
- Support: $25.60 and $24.70 have repeatedly attracted buyers, marking clear zones for accumulation.
- Resistance: $27.00 and $28.50 represent recent rally caps; breaking above could trigger a technical breakout.
- Momentum Indicators:
- RSI remains neutral, implying no immediate overbought or oversold risk, providing flexibility for new price trends.
- MACD is showing early bullish signals, especially following April’s stabilization and volume spikes.
- Volume Trends: Increased trading volume, notably amid director purchases in April, suggests heightened institutional and retail interest.
Collectively, Sonic Healthcare appears to be consolidating at a supportive technical base. Any catalyst—earnings, acquisition progress, or sector momentum—could spark a reversal beneficial to buyers.
Fundamental Analysis
Sonic Healthcare’s fundamental strengths distinguish it in global diagnostics:
- Consistent Revenue Growth: H1 FY2025 revenue reached A$4.7 billion, driven by organic momentum and recent acquisitions.
- Profitable Expansion: EBITDA (+12.3% YoY) and net profit (+17% YoY) outpace sector averages, reflecting operational scale and robust margin management despite higher input costs.
- Attractive Valuation:
- P/E ratio: 20.79 (forward)—competitive for a defensive sector leader.
- Price/Sales: 1.35; EV/EBITDA: 9.59.
- Dividend Yield: 4.11%; high payout ratio reflects recurring cash flows and shareholder commitment.
- Strategic Expansion: The LADR/Kramer Group acquisition is set to drive over A$80 million in EBITDA from July 2025 onwards.
- Structural Strengths:
- Global Diversification: Dominant in Australia, Germany, Switzerland, the UK, and significant US presence—diversifying risk and unlocking growth levers.
- Operational Efficiency and Brand Equity: Scale advantages maintain Sonic at the top of provider preferences, paired with a strong clinical reputation.
- Innovation: Digital health and lab automation investments are preparing Sonic for technological disruption.
With stable earnings, international scale, and recurring revenues, Sonic is a formidable contender locally and globally in the diagnostics space.
Volume and Liquidity
Liquidity and trading volume are often overlooked but are distinct strengths for Sonic Healthcare:
- Average Daily Volume: 1.16 million shares, supporting smooth entry/exit for investors.
- Market Capitalization: $12.52 billion offers depth, reducing price swing risk and ensuring analyst coverage.
- Float Structure: A balanced mix of institutional, retail, and insider ownership supports dynamic price discovery and future valuation confidence.
Recent volume increases, particularly around strategic events and director purchases, point to growing investor engagement and increased sophistication of the share base that may support sustainable price appreciation.
Catalysts and Positive Outlook
Multiple forward-looking catalysts position Sonic Healthcare for renewed growth and possible sector re-rating:
- Acquisition Integration: The completed LADR/Kramer Group acquisition is projected to lift EBITDA from July 2025, unlocking new revenue and operational synergies across Europe.
- European Market Expansion: Strengthened share in Germany and the broader EU increases cross-border reach and patient base.
- Digital Transformation: Ongoing investments in automation, digital reporting, and tele-diagnostics equip Sonic for scalable, cost-effective operations.
- Emerging Demand Drivers:
- Aging Populations: Sustained pathology and preventive testing demand worldwide.
- Post-Pandemic Normalization: Routine diagnostics approach pre-pandemic volumes—restoring high-margin revenues.
- Preventive Healthcare Focus: Policy shifts toward early detection, where Sonic is strategically positioned.
- ESG Credentials: A focus on environmental and social governance in diagnostics attracts ethically driven capital.
With these catalysts, Sonic Healthcare is well placed to capture a growing slice of global diagnostic spending, supporting both earnings and share price growth.
Investment Strategies
Sonic Healthcare’s current range and sector position offer several strategies to suit different investors:
- Short-Term (Tactical Positioning):
- Accumulating shares near key support ($25.60) could provide a base for upside, especially ahead of major acquisition integration updates.
- Neutral RSI and stabilizing MACD lower downside risk, increasing upside potential on positive news.
- Medium-Term (Event-Driven):
- Positioning for strong H2 FY2025 or post-acquisition integration benefits could anticipate likely analyst upgrades.
- Positive sector and macro trends—rising demand, expansionary health budgets—support an optimistic risk/return profile.
- Long-Term (Buy-and-Hold):
- Attractive 4.11% yield and low beta (0.43) make Sonic a solid defensive choice for income portfolios.
- Persistent global expansion, innovation, and strong management offer ongoing value, even through economic cycles.
For investors seeking to capitalize on a technical low or align exposure ahead of major catalysts, current conditions justify a renewed focus on Sonic Healthcare.
Is It the Right Time to Buy Sonic Healthcare?
With solid financials, operational growth, and positive technical setup, Sonic Healthcare presents a compelling opportunity for new and existing investors. Key advantages—strong cash generation, attractive yield, leading market share, and visible growth drivers—support a positive near- and medium-term outlook.
While integration and regulatory risks remain, Sonic’s global scale, innovation, and diversified earnings create a favorable risk-reward profile unique among ASX healthcare stocks. Its valuation remains attractive, and the integration of key acquisitions provides clear fundamental and technical upside potential.
In summary, Sonic Healthcare offers a rare combination of income, growth, and defensiveness—perfect for investors seeking quality exposure to the global diagnostics boom. At current levels, the risk-reward is especially attractive.
For those seeking opportunity, balance, and conviction in healthcare, Sonic Healthcare may be entering a new bullish phase through 2025 and beyond.
How to buy Sonic Healthcare stock in Australia?
Buying Sonic Healthcare shares online is now a straightforward and secure process for Australian investors, thanks to regulated brokers operating under ASIC oversight. Most platforms allow you to invest in Sonic Healthcare in just a few clicks. You can either buy shares outright (spot/cash buying) to become a shareholder, or trade Sonic Healthcare using CFDs, which let you speculate on price movements with leverage. Each method has its own features and risk profile—below, you’ll find a detailed comparison, followed by a dedicated broker selector further down the page to help you find the right fit.
Spot Buying (Cash Purchase)
A cash purchase means buying Sonic Healthcare shares directly on the Australian Securities Exchange (ASX), making you a part-owner of the company and eligible for dividends. Australian brokers typically charge a fixed commission per trade—often ranging from $5 to $20 per order, depending on the platform, with many offering $5 trades for smaller investors.
Important Example
Example:
Suppose the Sonic Healthcare share price is $26.06 AUD. With a $1,000 investment, you can buy approximately 38 shares ([$1,000 – $5 brokerage] ÷ $26.06 ≈ 38). If the share price rises by 10%, your shares are now worth $1,100.
Result: That’s a $100 gross gain, or +10% on your original investment, before considering any taxes or further fees.
Trading via CFD
CFDs (Contracts for Difference) allow you to speculate on Sonic Healthcare’s share price without physically owning the shares. CFDs offer leverage, meaning you can control a larger position with a smaller capital outlay. You’ll typically pay a spread (the difference between buy and sell prices), and if you hold your position overnight, you’ll incur a daily financing charge.
Important Example
Example:
You open a CFD position on Sonic Healthcare with $1,000 and select 5x leverage. This gives you exposure to $5,000 worth of shares. If Sonic Healthcare rises 8%, your position posts a gain of 8% × 5 = 40%.
Result: You pocket a $400 gain on a $1,000 deposit (excluding spread and overnight fees). Remember, leverage can magnify both gains and losses, so risk management is essential.
Final Advice
Always compare broker fees, trading conditions, and platform features before making your investment, as these can meaningfully impact your returns. Whether you opt for cash shares (to participate in dividends and growth) or prefer CFDs for trading flexibility and leverage, the right choice depends on your financial goals and risk appetite. To help you find the best ASIC-regulated brokers for buying Sonic Healthcare shares or trading via CFDs, consult the detailed comparator provided further down this page.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions, starting with the AMF in France, but also the Central Bank of Ireland, ASIC (Australia) and the FSA (Japan). Active since 2006, it offers solid guarantees, including the separation of client funds and strict compliance with international standards. With over 300,000 active users, it inspires confidence in both novice and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. Tutorials, demo accounts and free training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don't need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when you pay.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you're looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is a great choice.
Is it easy to withdraw money from AvaTrade?
Yes, AvaTrade offers a fast and secure withdrawal process. Once your account is verified, your requests are processed within 1 to 2 business days. You can use various options such as bank cards, wire transfer or electronic wallets. Everything is designed to offer you fast, clear and secure access.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions, starting with the AMF in France, but also the Central Bank of Ireland, ASIC (Australia) and the FSA (Japan). Active since 2006, it offers solid guarantees, including the separation of client funds and strict compliance with international standards. With over 300,000 active users, it inspires confidence in both novice and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. Tutorials, demo accounts and free training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don't need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when you pay.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you're looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is a great choice.
Is it easy to withdraw money from AvaTrade?
Yes, AvaTrade offers a fast and secure withdrawal process. Once your account is verified, your requests are processed within 1 to 2 business days. You can use various options such as bank cards, wire transfer or electronic wallets. Everything is designed to offer you fast, clear and secure access.
Is IG reliable?
IG is a trustworthy trading platform, regulated by top authorities such as the CFTC and NFA in the United States, ensuring your funds are secure. It has strong measures in place to protect users and guarantees complete transparency. Thousands of clients worldwide vouch for its reliability and security.
Why choose IG?
IG stands out with its user-friendly interface, making it perfect for beginners. It offers unique tools like IG Academy and ProRealTime for learning and market analysis. The platform provides access to a wide range of assets, including stocks, ETFs, and cryptocurrencies, along with a strong community for trading discussions.
What are the fees at IG?
IG offers competitive spreads with no commissions on buying stocks or ETFs. Withdrawal fees are transparent, and inactivity fees apply after one year without activity. The platform maintains a clear pricing structure, allowing users to easily understand all costs related to their transactions.
Who is IG for?
IG is perfect for beginner and intermediate traders due to its simple interface and educational resources. It also caters to experienced investors with advanced trading tools. Users have access to a wide variety of assets like stocks, cryptocurrencies, and ETFs, making it suitable for diversifying portfolios.
Is it easy to withdraw money from IG?
Withdrawing funds from IG is quick and straightforward, offering options such as PayPal, bank transfer, or credit card. Processing times are usually 1 to 3 business days. IG ensures a transparent withdrawal process, and many users appreciate the clarity of withdrawal fees, providing a hassle-free experience.
Is IG reliable?
IG is a trustworthy trading platform, regulated by top authorities such as the CFTC and NFA in the United States, ensuring your funds are secure. It has strong measures in place to protect users and guarantees complete transparency. Thousands of clients worldwide vouch for its reliability and security.
Why choose IG?
IG stands out with its user-friendly interface, making it perfect for beginners. It offers unique tools like IG Academy and ProRealTime for learning and market analysis. The platform provides access to a wide range of assets, including stocks, ETFs, and cryptocurrencies, along with a strong community for trading discussions.
What are the fees at IG?
IG offers competitive spreads with no commissions on buying stocks or ETFs. Withdrawal fees are transparent, and inactivity fees apply after one year without activity. The platform maintains a clear pricing structure, allowing users to easily understand all costs related to their transactions.
Who is IG for?
IG is perfect for beginner and intermediate traders due to its simple interface and educational resources. It also caters to experienced investors with advanced trading tools. Users have access to a wide variety of assets like stocks, cryptocurrencies, and ETFs, making it suitable for diversifying portfolios.
Is it easy to withdraw money from IG?
Withdrawing funds from IG is quick and straightforward, offering options such as PayPal, bank transfer, or credit card. Processing times are usually 1 to 3 business days. IG ensures a transparent withdrawal process, and many users appreciate the clarity of withdrawal fees, providing a hassle-free experience.
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including the AMF in France, as well as the FCA (UK), ASIC (Australia) and CySEC in Europe. With over 30 million users worldwide, eToro is widely recognized for its security and transparency. Based on our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don’t need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while investing.
You have access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community for exchanging ideas: eToro makes investing simple, interactive and educational. It's a bit like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of stocks or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposits are free, and withdrawals are set at $5. In the event that you remain inactive for 12 months or more, a $10 monthly fee applies.
Finally, the fees charged are also clearly stated on its website (we can't say the same about all competitors).
Who is eToro for?
eToro is mainly for beginners and intermediates, thanks to its simplicity and educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Is it easy to withdraw your money from eToro?
Yes, withdrawing your winnings from eToro is as easy as investing. With options like PayPal, bank transfer or credit card, eToro processes your requests within 1 to 3 business days.
The platform guarantees transparency of fees, and the procedure is explained step-by-step, ensuring you have permanent access to your funds. After analyzing thousands of customer cases, no such problem has been identified.
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including the AMF in France, as well as the FCA (UK), ASIC (Australia) and CySEC in Europe. With over 30 million users worldwide, eToro is widely recognized for its security and transparency. Based on our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don’t need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while investing.
You have access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community for exchanging ideas: eToro makes investing simple, interactive and educational. It's a bit like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of stocks or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposits are free, and withdrawals are set at $5. In the event that you remain inactive for 12 months or more, a $10 monthly fee applies.
Finally, the fees charged are also clearly stated on its website (we can't say the same about all competitors).
Who is eToro for?
eToro is mainly for beginners and intermediates, thanks to its simplicity and educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Is it easy to withdraw your money from eToro?
Yes, withdrawing your winnings from eToro is as easy as investing. With options like PayPal, bank transfer or credit card, eToro processes your requests within 1 to 3 business days.
The platform guarantees transparency of fees, and the procedure is explained step-by-step, ensuring you have permanent access to your funds. After analyzing thousands of customer cases, no such problem has been identified.
Our 7 tips for buying Sonic Healthcare stock
| 📊 Step | 📝 Specific tip for Sonic Healthcare |
|---|---|
| Analyse the market | Review the healthcare sector’s outlook in Australia and globally, focusing on the demand for diagnostic services and Sonic Healthcare’s strong market positions. |
| Choose the right trading platform | Compare ASX brokers that offer low transaction fees, strong research tools, and easy access to Sonic Healthcare shares for Australian investors. |
| Define your investment budget | Consider how much of your portfolio to allocate, balancing Sonic Healthcare’s defensive qualities and steady dividends with diversification in other sectors. |
| Choose a strategy (short or long term) | For most investors, a long-term approach suits Sonic Healthcare, given its reliable dividends, stable revenue, and global growth initiatives. |
| Monitor news and financial results | Stay updated on Sonic Healthcare’s earnings reports, acquisition integrations, and any changes in healthcare regulations that may affect profitability. |
| Use risk management tools | Utilise stop-loss orders or set a maximum loss amount to protect your capital, especially considering healthcare regulatory and integration risks. |
| Sell at the right time | Reassess your position around major announcements, such as acquisition outcomes or earnings releases, and consider profit-taking if the stock reaches resistance levels. |
The latest news about Sonic Healthcare
Sonic Healthcare reported a 17% year-on-year net profit increase in its latest half-year results.
The company’s revenue reached A$4.7 billion with net profit rising to A$236.7 million and EBITDA up 12.3% to A$827 million, reflecting robust demand for its diagnostic services in Australia and internationally. This strong financial performance underpins Sonic’s ongoing earnings momentum and supports the current attractive dividend yield, providing a positive signal to Australian investors focused on income and growth.
Directors showed strong confidence in Sonic Healthcare through insider share purchases in April 2025.
Multiple members of the senior management team increased their holdings in the company, an action widely regarded as a constructive signal of management’s belief in Sonic’s strategy and future earnings trajectory. This insider activity supports market sentiment and is likely to be viewed favorably by Australian institutional and retail investors assessing governance quality and alignment of interests.
Following the announcement of a major acquisition, Sonic Healthcare anticipates a significant EBITDA boost from July 2025.
The upcoming integration of the LADR/Kramer Group, valued at approximately A$700 million, is projected to contribute over A$80 million annually to EBITDA. This move not only reflects Sonic’s proactive growth strategy but also demonstrates management’s intention to further diversify earnings streams and solidify the company’s leading position in the global diagnostics sector, with benefits that will be closely watched by the Australian market.
Sonic Healthcare’s ongoing investments in digital transformation and laboratory automation enhance operational efficiency and service quality.
The company’s focus on digital health solutions and the automation of core processes is expected to drive continued cost efficiencies, support higher margins, and enable scalable growth as demand for diagnostic services increases. For the Australian market, these initiatives reinforce Sonic’s competitive advantage in both urban and regional settings, bolstering its long-term outlook.
Investor interest in Sonic Healthcare is increasing, reflected by recent gains in share price and higher trading volumes.
Despite broader market volatility, Sonic’s stock has appreciated by 1.2% over the last 24 hours and remains relatively stable over the past week, with average daily trading volumes at 1.16 million shares. This pattern suggests renewed confidence from local investors, likely driven by the company’s healthy financials, dividend outlook, and visible progress in executing its long-term strategy.
FAQ
What is the latest dividend for Sonic Healthcare stock?
Sonic Healthcare currently pays a dividend, with the most recent annual dividend rate at $1.07 per share. The last ex-dividend date was March 5, 2025. At the current share price of $26.06, this reflects an attractive yield for investors. The payout ratio sits at 93.15%, indicating a strong commitment to returning profits to shareholders, in line with the company’s history of consistent dividend payments.
What is the forecast for Sonic Healthcare stock in 2025, 2026, and 2027?
Based on the current share price of $26.06, the projected prices are $33.88 by end of 2025, $39.09 by end of 2026, and $52.12 by end of 2027. Sonic Healthcare benefits from robust sector demand, ongoing acquisition-driven growth, and a stable global presence. Notably, the expected earnings boost from recent acquisitions, coupled with favorable industry trends, supports an optimistic forward outlook.
Should I sell my Sonic Healthcare shares?
Holding Sonic Healthcare shares may be prudent, given the company’s resilient business model, reasonable current valuation, and consistent dividend payments. Sonic is strategically positioned in global diagnostics, with a history of solid earnings growth and ongoing expansion. With its strong market position, experienced leadership, and defensive sector exposure, the fundamentals suggest continued potential for mid- to long-term investors.
How are Sonic Healthcare dividends and capital gains taxed for Australian investors?
For Australian residents, dividends from Sonic Healthcare are generally subject to income tax but many are fully or partially franked, offering valuable tax credits that can offset payable tax. Capital gains are taxed at your marginal rate, with a 50% discount if shares are held for more than 12 months. No withholding tax applies domestically, and Sonic Healthcare is eligible for all standard local tax treatment.
What is the latest dividend for Sonic Healthcare stock?
Sonic Healthcare currently pays a dividend, with the most recent annual dividend rate at $1.07 per share. The last ex-dividend date was March 5, 2025. At the current share price of $26.06, this reflects an attractive yield for investors. The payout ratio sits at 93.15%, indicating a strong commitment to returning profits to shareholders, in line with the company’s history of consistent dividend payments.
What is the forecast for Sonic Healthcare stock in 2025, 2026, and 2027?
Based on the current share price of $26.06, the projected prices are $33.88 by end of 2025, $39.09 by end of 2026, and $52.12 by end of 2027. Sonic Healthcare benefits from robust sector demand, ongoing acquisition-driven growth, and a stable global presence. Notably, the expected earnings boost from recent acquisitions, coupled with favorable industry trends, supports an optimistic forward outlook.
Should I sell my Sonic Healthcare shares?
Holding Sonic Healthcare shares may be prudent, given the company’s resilient business model, reasonable current valuation, and consistent dividend payments. Sonic is strategically positioned in global diagnostics, with a history of solid earnings growth and ongoing expansion. With its strong market position, experienced leadership, and defensive sector exposure, the fundamentals suggest continued potential for mid- to long-term investors.
How are Sonic Healthcare dividends and capital gains taxed for Australian investors?
For Australian residents, dividends from Sonic Healthcare are generally subject to income tax but many are fully or partially franked, offering valuable tax credits that can offset payable tax. Capital gains are taxed at your marginal rate, with a 50% discount if shares are held for more than 12 months. No withholding tax applies domestically, and Sonic Healthcare is eligible for all standard local tax treatment.
